A Comparison of the Circulating Endocan Levels between the Inflammatory and Malignant Diseases of the Same Organ: The Breast

References

• Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 2006;1765(1):25–37. doi:https://doi.org/10.1016/j.bbcan.2005.08.004.
   PubMed Web of Science ®Google Scholar
• Lassalle P, Molet S, Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271(34):20458–20464. doi:https://doi.org/10.1074/jbc.271.34.20458.
   PubMed Web of Science ®Google Scholar
• Chew BS, Ghazali R, Othman H, et al. Endocan expression in placenta of women with hypertension. J Obstet Gynaecol Res. 2019;45(2):345–351. doi:https://doi.org/10.1111/jog.13836.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee HH, Yoon YE, et al. Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma. Oncotarget 2018;9(1):662–667. doi:https://doi.org/10.18632/oncotarget.23087.
   PubMedGoogle Scholar
• Delehedde M, Devenyns L, Maurage CA, Vives RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027. doi:https://doi.org/10.1155/2013/705027.
   PubMedGoogle Scholar
• Huang X, Chen C, Wang X, et al. Prognostic value of endocan expression in cancers: evidence from meta-analysis. OTT. 2016;9:6297–6304. doi:https://doi.org/10.2147/OTT.S110295.
   Web of Science ®Google Scholar
• Aciksari G, Kavas M, Atici A, et al. Endocan levels and endothelial dysfunction in patients with sarcoidosis. Angiology 2018;69(10):878–883. doi:https://doi.org/10.1177/0003319718775283.
   PubMed Web of Science ®Google Scholar
• Kul A, Ates O, Melikoglu MA, et al. Endocan measurement for active Behcet Disease. Arch Rheumatol. 2017;32(3):197–202. doi:https://doi.org/10.5606/ArchRheumatol.2017/6072.
   PubMed Web of Science ®Google Scholar
• Ozalper V, Kara M, Tanoglu A, et al. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Rheumatol. 2017;36(9):2071–2077. doi:https://doi.org/10.1007/s10067-016-3532-2.
   PubMed Web of Science ®Google Scholar
• Kadayifci FZ, Karadag MG. The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis. Eur J Rheumatol. 2018;5(1):1–4. doi:https://doi.org/10.5152/eurjrheum.2017.17287.
   PubMed Web of Science ®Google Scholar
• Ates O, Gedik E, Sunar V, Altundag K. Serum endocan level and its prognostic significance in breast cancer patients. J Oncol Sci. 2018;4(1):15–18. doi:https://doi.org/10.1016/j.jons.2017.11.004.
   Google Scholar
• Iturralde-RosasPriego P, GomezPedroso-Rea J, Mancera-Resendiz MA, et al. Idiopathic granulomatous mastitis: a new algorithm. Obstet Gynecol Int J. 2019;10:348–‒353. doi:https://doi.org/10.15406/ogij.2019.10.00465.
   Google Scholar
• Scherpereel A, Gentina T, Grigoriu B, et al. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63(18):6084–6089.
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhang SM, Hu RL, et al. Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol. 2008;14(28):4562–4568. doi:https://doi.org/10.3748/wjg.14.4562.
   PubMed Web of Science ®Google Scholar
• Laloglu E, Kumtepe Y, Aksoy H, Yilmaz E. Serum endocan levels in endometrial and ovarian cancer. J Clin Lab Anal. 2017;31(5):e22079. doi:https://doi.org/10.1002/jcla.22079.
   Web of Science ®Google Scholar
• Sagara A, Igarashi K, Otsuka M, et al. Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Res Treat. 2017;161(2):269–278. doi:https://doi.org/10.1007/s10549-016-4057-8.
   PubMed Web of Science ®Google Scholar
• Gok M, Kundi H, Kiziltunc E, Topcuoglu C, Ornek E. Endocan levels and coronary collateral circulation in stable angina pectoris: a pilot study. Angiology 2018;69(1):43–48. doi:https://doi.org/10.1177/0003319717703835.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Papamichael C, Stamatelopoulos KS, et al. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum. 2007;56(6):1985–1993. doi:https://doi.org/10.1002/art.22634.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Takemura M, Sato M, et al. Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis. Int J Rheum Dis. 2014;17(1):26–33. doi:https://doi.org/10.1111/1756-185x.12021.
   PubMed Web of Science ®Google Scholar
• Avgerinou G, Tousoulis D, Siasos G, et al. Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis. Int J Cardiol. 2011;151(3):382–383. doi:https://doi.org/10.1016/j.ijcard.2011.06.112.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Breast cancer: prevention and control [Internet]. Geneva, Switzerland: WHO; 2020. https://www.who.int/cancer/detection/breastcancer/en/. Accessed May 05, 2020.
   Google Scholar
• Sauter ER. Reliable biomarkers to identify new and recurrent cancer. Eur J Breast Health 2017;13(4):162–167. doi: https://doi.org/10.5152/ejbh.
   PubMed Web of Science ®Google Scholar
• Suraj J, Kurpinska A, Zakrzewska A, et al. Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using mass spectrometry-based method. Dis Model Mech. 2019;12 (3):dmm036269. doi:https://doi.org/10.1242/dmm.036269.
   Google Scholar
• Yigitbasi MR, Guntas G, Atak T, Sonmez C, Yalman H, Uzun H. The role of interleukin-33 as an inflammatory marker in differential diagnosis of idiopathic granulomatous mastitis and breast cancer. J Invest Surg. 2017;30(4):272–276. doi:https://doi.org/10.1080/08941939.2016.1240270.
   PubMed Web of Science ®Google Scholar
• Li J. Diagnosis and treatment of 75 patients with idiopathic lobular granulomatous mastitis. J Invest Surg. 2019;32(5):414–420. doi:https://doi.org/10.1080/08941939.2018.1424270.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Toshikuni N, George J, et al. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer 2014;5(3):221–230. doi:https://doi.org/10.7150/jca.7691.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang S, Zhou Q, Wang Y, Xia R. Endocan, a potential prognostic and diagnostic biomarker of acute leukemia. Mol Cell Biochem. 2014;395(1–2):117–123. doi:https://doi.org/10.1007/s11010-014-2117-0.
   PubMed Web of Science ®Google Scholar
• Ji NY, Kim YH, Jang YJ, et al. Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer. Cancer Sci. 2010;101(10):2248–2253. doi:https://doi.org/10.1111/j.1349-7006.2010.01665.x.
   PubMed Web of Science ®Google Scholar
• Altintoprak F, Karakece E, Kivilcim T, et al. Idiopathic granulomatous mastitis: an autoimmune disease? ScientificWorldJournal 2013;2013:148727. doi:https://doi.org/10.1155/2013/148727.
   PubMed Web of Science ®Google Scholar
• Ozel L, Unal A, Unal E, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today 2012; 42(8):729–733. doi:https://doi.org/10.1007/s00595-011-0046-z..
   PubMed Web of Science ®Google Scholar